- Home
- NXL vs AEI Comparison
NXL vs AEI Comparison
Compare NXL & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXL
- AEI
- Stock Information
- Founded
- NXL 2010
- AEI 2014
- Country
- NXL United States
- AEI United States
- Employees
- NXL N/A
- AEI N/A
- Industry
- NXL Medical Specialities
- AEI Building operators
- Sector
- NXL Health Care
- AEI Real Estate
- Exchange
- NXL Nasdaq
- AEI Nasdaq
- Market Cap
- NXL 10.0M
- AEI 12.0M
- IPO Year
- NXL 2022
- AEI N/A
- Fundamental
- Price
- NXL $3.23
- AEI $0.93
- Analyst Decision
- NXL Hold
- AEI
- Analyst Count
- NXL 1
- AEI 0
- Target Price
- NXL N/A
- AEI N/A
- AVG Volume (30 Days)
- NXL 533.6K
- AEI 59.7K
- Earning Date
- NXL 11-08-2024
- AEI 11-14-2024
- Dividend Yield
- NXL N/A
- AEI N/A
- EPS Growth
- NXL N/A
- AEI N/A
- EPS
- NXL N/A
- AEI N/A
- Revenue
- NXL $162,078.00
- AEI $13,191,488.00
- Revenue This Year
- NXL $56.86
- AEI N/A
- Revenue Next Year
- NXL $167.44
- AEI N/A
- P/E Ratio
- NXL N/A
- AEI N/A
- Revenue Growth
- NXL 26.00
- AEI N/A
- 52 Week Low
- NXL $0.25
- AEI $0.46
- 52 Week High
- NXL $4.49
- AEI $2.05
- Technical
- Relative Strength Index (RSI)
- NXL 42.43
- AEI 34.87
- Support Level
- NXL $3.25
- AEI $0.86
- Resistance Level
- NXL $4.49
- AEI $1.20
- Average True Range (ATR)
- NXL 0.35
- AEI 0.13
- MACD
- NXL -0.17
- AEI -0.02
- Stochastic Oscillator
- NXL 7.26
- AEI 15.63
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.